2018
DOI: 10.1186/s12885-018-4141-z
|View full text |Cite
|
Sign up to set email alerts
|

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer

Abstract: Background: The subtype of claudin-low breast cancer can be reliably determined only by gene-expression profiling. Attempts have been made to develop immunohistochemical surrogates, which nearly always focus on membranous claudin expression. Methods: We assessed the immunohistochemical expression of both membranous and cytoplasmic claudins 3, 4 and 7 in a series of 197 non-metastatic breast cancers, enriched with triple-negative breast cancers (TNBCs; 60%). The expression of epithelial-to-mesenchymal transitio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 42 publications
(51 reference statements)
0
10
0
3
Order By: Relevance
“…The levels of claudin 7 were reduced with melatonin treatment in both TNBC cell lines. In cancer, claudins appear to be linked to worse prognosis (65,66). Based on the results found in the migration and invasion events, we suggest that the low expression of claudin 7 would imply a better scenario of cancer prognosis.…”
Section: Pik3camentioning
confidence: 68%
“…The levels of claudin 7 were reduced with melatonin treatment in both TNBC cell lines. In cancer, claudins appear to be linked to worse prognosis (65,66). Based on the results found in the migration and invasion events, we suggest that the low expression of claudin 7 would imply a better scenario of cancer prognosis.…”
Section: Pik3camentioning
confidence: 68%
“…CLND3 encodes Claudin 3, which is associated with the tight junction representing cell-to-cell adhesion (38). The association between CLND3 and cancer remains controversial; upregulation of CLND3 has been reported to act as a biomarker and a predictor of poor prognosis in different types of cancer, including triple-negative breast, oesophageal and gastric cancer (39,40). By contrast, downregulation of CLDN3 has been demonstrated to be associated with the progression and metastasis of lung squamous cell carcinoma (41).…”
Section: Kif11 Expression -------------------------------------------mentioning
confidence: 99%
“… 58 , 59 IHC revealed high claudin-7 expression in triple-negative breast cancer, which correlated with low c-kit expression and a higher tumor grade and has been shown to be an independent predictor of low recurrence-free survival. 44 , 60 The expression of claudin-7 in gastric cancer was also significantly upregulated and persisted during tumor progression. The overall survival time of patients with high claudin-7 expression was decreased.…”
Section: Claudin-7 and Cancer: Causal Correlationmentioning
confidence: 99%